HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of cardiopulmonary bypass during resection of locally advanced thoracic malignancies: a 10-year two-center experience.

Abstract
The use of cardiopulmonary bypass (CPB) for locally advanced thoracic malignancies is highly controversial. The purpose of this study was to document the techniques and results of CPB to facilitate the resection of complex thoracic malignancies and to identify common themes that provided for successful outcomes. This was a retrospective study that took place from January 1992 to September 2002. Fourteen consecutive patients (median age, 59 years; age range, 18 to 69 years; seven men and seven women) underwent CPB during the resection of locally advanced thoracic malignancies at two Boston hospitals. CPB was planned in 8 of 14 patients (57%) with centrally located tumors, while 6 of 14 patients (43%) required emergent institution of CPB due to injury of the superior vena cava (2 patients), inferior vena cava (2 patients), or pulmonary artery (2 patients). Complete microscopic resection was achieved in 12 of 14 patients (86%). The operative mortality rate was 1 of 14 patients (7%) due to pulmonary embolism (ie, the elective group). The median ICU and hospital lengths of stay were 5 and 9 days, respectively. The overall 1-year, 3-year, and 5-year survival rates were 57%, 36%, and 21%, respectively. The planned use of CPB to facilitate complete resection of thoracic malignancies should be considered only after careful patient selection. The availability of CPB also provides a safety net in the event of injury to vascular structures during tumor resection.
AuthorsJohn G Byrne, Marzia Leacche, Arvind K Agnihotri, Subroto Paul, Raphael Bueno, Douglas J Mathisen, David J Sugarbaker
JournalChest (Chest) Vol. 125 Issue 4 Pg. 1581-6 (Apr 2004) ISSN: 0012-3692 [Print] United States
PMID15078778 (Publication Type: Journal Article, Multicenter Study)
Topics
  • Adolescent
  • Adult
  • Aged
  • Cardiopulmonary Bypass (methods)
  • Female
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Postoperative Complications
  • Retrospective Studies
  • Thoracic Neoplasms (surgery)
  • Treatment Outcome
  • Vena Cava, Inferior (injuries)
  • Vena Cava, Superior (injuries)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: